Marc Desch

Effect of Avenciguat on Albuminuria in Patients with CKD

Hiddo J.L. Heerspink, David Cherney, Abdul Halim Abdul Gafor et al. · Journal of the American Society of Nephrology · 2024 · 36 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Rationale, design, and protocol of a randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous thrombosis

José M. Ferro, Francesco Dentali, Jonathan M. Coutinho et al. · International Journal of Stroke · 2018 · 25 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate

Walter Ageno, Ivan Benaduce Casella, Chee Kok Han et al. · Thrombosis and Haemostasis · 2016 · 16 citations

Medicine, Pharmacology, Pharmacotherapy +17

Safety, tolerability, pharmacodynamics and pharmacokinetics of the soluble guanylyl cyclase activator <scp>BI</scp> 685509 in patients with diabetic kidney disease: A randomized trial

David Z.I. Cherney, Dick de Zeeuw, Hiddo J.L. Heerspink et al. · Diabetes Obesity and Metabolism · 2023 · 15 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Profile of Patients Diagnosed With Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE™ Study

Samuel Z. Goldhaber, Walter Ageno, Ivan Benaduce Casella et al. · The American Journal of Medicine · 2020 · 13 citations

Medicine, Internal Medicine, Clinical Epidemiology +9